We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+22.82%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$701M
AUM Growth
+$121M
Cap. Flow
+$42.4M
Cap. Flow %
6.05%
Top 10 Hldgs %
81.47%
Holding
27
New
2
Increased
7
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
MZOR
Mazor Robotics Ltd.
MZOR
+$19.4M
2
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$12.7M
3
THOR
THORATEC CORPORATION
THOR
+$11.6M
4
AXDX
Accelerate Diagnostics
AXDX
+$4.59M
5
TTHI
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
+$2.76M

Top Sells

Rank Stock Value
1
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
+$11.2M
2
THC icon
Tenet Healthcare
THC
+$1.04M
3
MNKD icon
MannKind Corp
MNKD
+$356K
4
ACOR
Acorda Therapeutics
ACOR
+$254K
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$12.6K

Sector Composition

Rank Sector Weight
1 Healthcare 66.33%
2 Consumer Staples 0.3%
3 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$92.7M 13.23%
3,265,457
– –
THOR
2
DELISTED
THORATEC CORPORATION
THOR
$83.4M 11.89%
2,236,349
+331,400
+17% +$11.6M
THC icon
3
Tenet Healthcare
THC
$22.6B
$72.3M 10.32%
1,755,950
-24,750
-1% -$1.04M
ACOR
4
DELISTED
Acorda Therapeutics
ACOR
$68M 9.7%
16,578
-59
-0.4% -$254K
AXDX
5
DELISTED
Accelerate Diagnostics
AXDX
$62.4M 8.9%
465,451
+51,475
+12% +$4.59M
MZOR
6
DELISTED
Mazor Robotics Ltd.
MZOR
$54.3M 7.74%
3,213,274
+1,332,333
+71% +$19.4M
OPK icon
7
Opko Health
OPK
$1.25B
$51.2M 7.31%
5,814,742
+1,000
+0% +$8.02K
NXTM
8
DELISTED
NxStage Medical Inc.
NXTM
$32.4M 4.62%
2,462,313
– –
MAKO
9
DELISTED
MAKO SURGICAL CORP COM
MAKO
$28.1M 4.01%
953,513
– –
TSRO
10
DELISTED
TESARO, Inc.
TSRO
$26.2M 3.74%
677,112
– –
HNSN
11
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$24.9M 3.54%
1,641,743
+810,181
+97% +$12.7M
ARAY icon
12
Accuray
ARAY
$29M
$21.2M 3.02%
2,868,425
– –
GTIV
13
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
$19.1M 2.72%
1,582,418
– –
TTHI
14
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$17.6M 2.51%
4,287,412
+700,915
+20% +$2.76M
IRWD icon
15
Ironwood Pharmaceuticals
IRWD
$626M
$13.1M 1.87%
1,320,570
-1,286
-0.1% -$12.6K
PACB icon
16
Pacific Biosciences
PACB
$432M
$10.8M 1.54%
1,961,688
– –
WBMD
17
DELISTED
WebMD Health Corp.
WBMD
$6.35M 0.91%
222,512
+75,400
+51% +$2.35M
VRML
18
DELISTED
Vermillion, Inc.
VRML
$4.09M 0.58%
2,799,980
– –
AGEN
19
Agenus
AGEN
$275M
$3.4M 0.48%
62,446
– –
BIIB icon
20
Biogen
BIIB
$30.4B
$2.79M 0.4%
11,603
– –
YTEN
21
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$2.09M 0.3%
29
– –
ONCT
22
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1.75M 0.25%
617
-2,254
-79% -$11.2M
AVEO
23
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.18M 0.17%
57,500
– –
BIOL
24
DELISTED
Biolase, Inc.
BIOL
$1.11M 0.16%
+47
New +$1.51M
LTS
25
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$302K 0.04%
166,849
– –
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q3 2013 Portfolio in Review

As of Q3 2013, Oracle Investment Management held 27 positions worth $701M, up 21% from $580M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Oracle Investment Management deployed $42.4M of net new capital in Q3 2013, opening 2 new positions and adding to 7 existing holdings. Its largest new stake was Biolase, Inc.: 47 shares worth $1.11M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 75% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Oncternal Therapeutics, Inc. Common Stock, an estimated $11.2M trimmed.

  • Oracle Investment Management's largest Q3 2013 buy was Biolase, Inc.: 47 shares worth $1.11M.
  • Oracle Investment Management added most to Mazor Robotics Ltd. in Q3 2013, an estimated $19.4M increase.
  • Oracle Investment Management's biggest Q3 2013 reduction was Oncternal Therapeutics, Inc. Common Stock, cutting an estimated $11.2M.
  • Oracle Investment Management fully exited MannKind Corp in Q3 2013, selling an estimated $356K.
  • Oracle Investment Management's ten largest holdings make up 81% of its $701M portfolio in Q3 2013.
  • Oracle Investment Management opened 2 new positions and closed 1 in Q3 2013.
  • Oracle Investment Management's portfolio value rose 21% quarter-over-quarter to $701M.

Based on Oracle Investment Management's 13F filing for Q3 2013, filed 14 Nov 2013.